SCALAMBRA, LAURA
SCALAMBRA, LAURA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Dottorandi
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay
2024 Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Palladini A.; Lollini P.L.
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?
2024 Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Olga Maria Pittino, Lorena Landuzzi, Arianna Palladini, Patrizia Nanni, Pier-Luigi Lollini
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis
2023 Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; Grzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy
2023 Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Lollini P.-L.
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC
2022 Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; Scalambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine
2022 Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeyer, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft
2021 Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Giusti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
2021 Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Nironi, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi
IFN-γ and CD38 in Hyperprogressive Cancer Development
2021 Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco; Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay | Ruzzi F.; Semprini M.S.; Scalambra L.; Angelicola S.; Cappello C.; Pittino O.M.; Nanni P.; Pallad...ini A.; Lollini P.L. | 2024-01-01 | METHODS IN CELL BIOLOGY | - | 1.01 Articolo in rivista | - |
| Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? |
Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, Laura Scalambra, Stefania Angelicola, Ol...ga Maria Pittino, Lorena Landuzzi, Arianna Palladini, Patrizia Nanni, Pier-Luigi Lollini |
2024-01-01 | CELL COMMUNICATION AND SIGNALING | - | 1.01 Articolo in rivista | Lipid rafts review.pdf |
| Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis | Ruzzi, F; Palladini, A; Clemmensen, S; Strobaek, A; Buijs, N; Domeyer, T; Dorosz, J; Soroka, V; G...rzadziela, D; Rasmussen, CJ; Nielsen, IB; Soegaard, M; Semprini, MS; Scalambra, L; Angelicola, S; Landuzzi, L; Lollini, PL; Thorn, M | 2023-01-01 | CANCER RESEARCH | - | 1.06 Abstract in rivista | - |
| Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy | Ruzzi F.; Semprini M.S.; Scalambra L.; Palladini A.; Angelicola S.; Cappello C.; Pittino O.M.; Na...nni P.; Lollini P.-L. | 2023-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | VLP Review ijms-24-12963-v2.pdf |
| ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC | Ruzzi, Francesca; Angelicola, Stefania; Landuzzi, Lorena; Nironi, Elena; Semprini, Maria Sofia; S...calambra, Laura; Altimari, Annalisa; Gruppioni, Elisa; Fiorentino, Michelangelo; Giunchi, Francesca; Ferracin, Manuela; Astolfi, Annalisa; Indio, Valentina; Ardizzoni, Andrea; Gelsomino, Francesco; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2022-01-01 | TRANSLATIONAL LUNG CANCER RESEARCH | - | 1.01 Articolo in rivista | ADK-VR2 TLCR.pdf; tlcr-11-11-2216-coif.zip |
| Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine | Ruzzi, Francesca; Palladini, Arianna; Clemmensen, Stine; Strøbæk, Anette; Buijs, Nicolaas; Domeye...r, Tanja; Dorosz, Jerzy; Soroka, Vladislav; Grzadziela, Dagmara; Rasmussen, Christina Jo; Nielsen, Ida Busch; Soegaard, Max; Semprini, Maria Sofia; Scalambra, Laura; Angelicola, Stefania; Landuzzi, Lorena; Lollini, Pier-Luigi; Thorn, Mette | 2022-01-01 | BIOMEDICINES | - | 1.01 Articolo in rivista | biomedicines-10-02654-v2.pdf; biomedicines-10-02654-s001.zip |
| Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft | Landuzzi, Lorena; Palladini, Arianna; Ceccarelli, Claudio; Asioli, Sofia; Nicoletti, Giordano; Gi...usti, Veronica; Ruzzi, Francesca; Ianzano, Marianna L; Scalambra, Laura; Laranga, Roberta; Balboni, Tania; Arigoni, Maddalena; Olivero, Martina; Calogero, Raffaele A; De Giovanni, Carla; Dall'Ora, Massimiliano; Di Oto, Enrico; Santini, Donatella; Foschini, Maria Pia; Cucchi, Maria Cristina; Zanotti, Simone; Taffurelli, Mario; Nanni, Patrizia; Lollini, Pier-Luigi | 2021-01-01 | SCIENTIFIC REPORTS | - | 1.01 Articolo in rivista | PDX Breast Sci Rep small.pdf |
| Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression | Giusti, Veronica; Ruzzi, Francesca; Landuzzi, Lorena; Ianzano, Marianna L; Laranga, Roberta; Niro...ni, Elena; Scalambra, Laura; Nicoletti, Giordano; De Giovanni, Carla; Olivero, Martina; Arigoni, Maddalena; Calogero, Raffaele; Nanni, Patrizia; Palladini, Arianna; Lollini, Pier-Luigi | 2021-01-01 | ONCOGENESIS | - | 1.01 Articolo in rivista | HER-2 loss Oncogenesis.pdf; 41389_2021_360_MOESM1_ESM.pdf |
| IFN-γ and CD38 in Hyperprogressive Cancer Development | Angelicola, Stefania; Ruzzi, Francesca; Landuzzi, Lorena; Scalambra, Laura; Gelsomino, Francesco;... Ardizzoni, Andrea; Nanni, Patrizia; Lollini, Pier-Luigi; Palladini, Arianna | 2021-01-01 | CANCERS | - | 1.01 Articolo in rivista | CD38 cancers-13-00309-v2.pdf |